The impact of chronic comorbidities at the time of breast cancer diagnosis on quality of life, and emotional health following treatment in Canada.

<h4>Introduction</h4>Advances in breast cancer screening and treatment have led to an increasing number of breast cancer survivors. The objective of this study was to determine the impact of comorbidities on self-reported quality of life (QOL) and emotional health following a breast canc...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jasleen Arneja, Jennifer D Brooks
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/7d705637fc2542d0a50e5f0ba8f631e1
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:7d705637fc2542d0a50e5f0ba8f631e1
record_format	dspace
spelling	oai:doaj.org-article:7d705637fc2542d0a50e5f0ba8f631e12021-12-02T20:19:30ZThe impact of chronic comorbidities at the time of breast cancer diagnosis on quality of life, and emotional health following treatment in Canada.1932-620310.1371/journal.pone.0256536https://doaj.org/article/7d705637fc2542d0a50e5f0ba8f631e12021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0256536https://doaj.org/toc/1932-6203<h4>Introduction</h4>Advances in breast cancer screening and treatment have led to an increasing number of breast cancer survivors. The objective of this study was to determine the impact of comorbidities on self-reported quality of life (QOL) and emotional health following a breast cancer diagnosis and treatment.<h4>Methods</h4>Women with a personal history of breast cancer (N = 3,372) were identified from the cross-sectional Canadian Partnership Against Cancer (CPAC) Experiences of Cancer Patients in Transitions Survey. Multinomial (nominal) logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI) for the relationship between burden of comorbidities and overall QOL and emotional health (very poor/poor, fair, good, very good).<h4>Results</h4>Of the 3,372 participants, 57% reported at least one chronic condition at the time of breast cancer diagnosis. As the number of chronic conditions at diagnosis increased, the odds of reporting worse quality of life and emotional health following treatment also increased. Specifically, compared to women reporting very good QOL, for each additional chronic condition, women reported significantly higher odds of reporting good (OR = 1.22, 95% CI: 1.12, 1.32), fair (OR = 1.76, 95% CI: 1.58, 1.96), or poor/very poor (OR = 2.31, 95% CI: 1.86, 2.88) QOL. Similarly, for each additional comorbidity, women reported significantly higher odds of reporting good (OR = 1.17, 95% CI: 1.07, 1.28), fair (OR = 1.63, 95% CI: 1.46, 1.82), or poor/very poor (OR = 2.17, 95% CI: 1.81, 2.60) emotional health, relative to very good emotional health.<h4>Conclusion</h4>Breast cancer survivors coping with a high comorbidity burden experience worse overall QOL and emotional health following treatment. This highlights the importance of integrating information on comorbidities into survivorship care to improve the experience and overall outcomes of patients with complex needs.Jasleen ArnejaJennifer D BrooksPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 8, p e0256536 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Jasleen Arneja Jennifer D Brooks The impact of chronic comorbidities at the time of breast cancer diagnosis on quality of life, and emotional health following treatment in Canada.
description	<h4>Introduction</h4>Advances in breast cancer screening and treatment have led to an increasing number of breast cancer survivors. The objective of this study was to determine the impact of comorbidities on self-reported quality of life (QOL) and emotional health following a breast cancer diagnosis and treatment.<h4>Methods</h4>Women with a personal history of breast cancer (N = 3,372) were identified from the cross-sectional Canadian Partnership Against Cancer (CPAC) Experiences of Cancer Patients in Transitions Survey. Multinomial (nominal) logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI) for the relationship between burden of comorbidities and overall QOL and emotional health (very poor/poor, fair, good, very good).<h4>Results</h4>Of the 3,372 participants, 57% reported at least one chronic condition at the time of breast cancer diagnosis. As the number of chronic conditions at diagnosis increased, the odds of reporting worse quality of life and emotional health following treatment also increased. Specifically, compared to women reporting very good QOL, for each additional chronic condition, women reported significantly higher odds of reporting good (OR = 1.22, 95% CI: 1.12, 1.32), fair (OR = 1.76, 95% CI: 1.58, 1.96), or poor/very poor (OR = 2.31, 95% CI: 1.86, 2.88) QOL. Similarly, for each additional comorbidity, women reported significantly higher odds of reporting good (OR = 1.17, 95% CI: 1.07, 1.28), fair (OR = 1.63, 95% CI: 1.46, 1.82), or poor/very poor (OR = 2.17, 95% CI: 1.81, 2.60) emotional health, relative to very good emotional health.<h4>Conclusion</h4>Breast cancer survivors coping with a high comorbidity burden experience worse overall QOL and emotional health following treatment. This highlights the importance of integrating information on comorbidities into survivorship care to improve the experience and overall outcomes of patients with complex needs.
format	article
author	Jasleen Arneja Jennifer D Brooks
author_facet	Jasleen Arneja Jennifer D Brooks
author_sort	Jasleen Arneja
title	The impact of chronic comorbidities at the time of breast cancer diagnosis on quality of life, and emotional health following treatment in Canada.
title_short	The impact of chronic comorbidities at the time of breast cancer diagnosis on quality of life, and emotional health following treatment in Canada.
title_full	The impact of chronic comorbidities at the time of breast cancer diagnosis on quality of life, and emotional health following treatment in Canada.
title_fullStr	The impact of chronic comorbidities at the time of breast cancer diagnosis on quality of life, and emotional health following treatment in Canada.
title_full_unstemmed	The impact of chronic comorbidities at the time of breast cancer diagnosis on quality of life, and emotional health following treatment in Canada.
title_sort	impact of chronic comorbidities at the time of breast cancer diagnosis on quality of life, and emotional health following treatment in canada.
publisher	Public Library of Science (PLoS)
publishDate	2021
url	https://doaj.org/article/7d705637fc2542d0a50e5f0ba8f631e1
work_keys_str_mv	AT jasleenarneja theimpactofchroniccomorbiditiesatthetimeofbreastcancerdiagnosisonqualityoflifeandemotionalhealthfollowingtreatmentincanada AT jenniferdbrooks theimpactofchroniccomorbiditiesatthetimeofbreastcancerdiagnosisonqualityoflifeandemotionalhealthfollowingtreatmentincanada AT jasleenarneja impactofchroniccomorbiditiesatthetimeofbreastcancerdiagnosisonqualityoflifeandemotionalhealthfollowingtreatmentincanada AT jenniferdbrooks impactofchroniccomorbiditiesatthetimeofbreastcancerdiagnosisonqualityoflifeandemotionalhealthfollowingtreatmentincanada
_version_	1718374173489758208

The impact of chronic comorbidities at the time of breast cancer diagnosis on quality of life, and emotional health following treatment in Canada.

Ejemplares similares